Skip to content
Webe Honey – Lifestyle
Author:
InflaRx N.V.
InflaRx Regains Compliance with Nasdaq Minimum Bid Price Requirement
April 28, 2026
InflaRx Reports New Mechanistic Data for Izicopan Supporting its Potential as a Best-in-Class C5aR Inhibitor
April 9, 2026
InflaRx Announces Participation in the Raymond James 2026 Biotech Innovation Symposium
March 31, 2026
InflaRx to Report Full Year 2025 Results on March 19, 2026
March 12, 2026
←
Previous Page
1
2